Cataract surgery and Inflammation – the role for preoperative NSAIDs (pre-CIN)

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512268-77-00

Enrollment

120

Registered

2024-10-01

Start date

2024-10-02

Completion date

Unknown

Last updated

2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

Laser flare

Interventions

DRUGNEVANAC 3 mg/ml eye drops

DRUGsuspension

DRUGSpersadex 1 mg/ml øyedråper

DRUGoppløsning

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Laser flare	—

Countries

Norway

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026